Vaxart【VXRT】株式ニュース

名称	銘柄コード	市場	種別
Vaxart Inc	VXRT	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0572	-7.66%	0.69	08:59:03

始値	安値	高値	終値	前日終値
0.755	0.6722	0.7599	0.6902	0.7472

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/20	19:10	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/18	05:05	GLOBE	Vaxart Provides Business Update
2024/6/17	19:02	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/6/14	19:03	EDGAR2	Form 8-K - Current report
2024/6/14	08:07	GLOBE	Vaxart Announces $40 Million Underwritten Offering of Common..
2024/6/14	06:26	EDGAR2	Form 8-K - Current report
2024/6/14	05:36	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/14	05:15	GLOBE	Vaxart Receives BARDA-Funded Project NextGen Award Valued Up..
2024/6/14	05:07	EDGAR2	Form 8-K - Current report
2024/6/13	05:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/13	05:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/13	05:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/13	05:39	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/6/13	05:38	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/24	05:01	GLOBE	Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
2024/5/14	05:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/14	05:03	EDGAR2	Form 8-K - Current report
2024/5/14	05:01	GLOBE	Vaxart Provides Business Update and Reports First Quarter..
2024/5/13	20:10	IHMARKETNEWS	U.S. Futures Climb Amid High Expectations for Inflation..
2024/5/07	21:00	GLOBE	Vaxart to Host First Quarter 2024 Business Update and..
2024/4/30	21:00	GLOBE	Vaxart Announces Positive Results for Its Bivalent Norovirus..
2024/3/27	21:00	GLOBE	Vaxart to Present at World Vaccine Congress Washington 2024..
2024/3/20	21:00	GLOBE	Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing..
2024/3/15	05:01	GLOBE	Vaxart Provides Business Update and Reports Full Year 2023..
2024/3/14	20:41	IHMARKETNEWS	U.S. Stock Futures Rise Ahead Of PPI and Retail Sales; Oil..
2024/3/07	22:00	GLOBE	Vaxart to Host Full Year 2023 Business Update and Financial..
2024/3/06	23:23	EDGAR2	Form 8-K - Current report
2024/3/06	22:00	GLOBE	Vaxart, Inc. Appoints Steven Lo as President, Chief..
2024/3/01	06:30	EDGAR2	Form 8-K - Current report
2024/2/16	06:10	EDGAR2	Form 8-K - Current report
2024/2/14	07:16	EDGAR2	Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/05	22:00	GLOBE	Vaxart Announces Publication in Vaccines of Non-Human..
2024/2/03	06:49	EDGAR2	Form 8-K/A - Current report: [Amend]
2024/1/20	07:14	EDGAR2	Form 8-K - Current report
2024/1/20	06:30	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/1/19	22:30	GLOBE	Vaxart Receives $9.27 Million BARDA Project NextGen Award to..
2024/1/17	07:18	EDGAR2	Form 8-K - Current report
2024/1/16	23:25	GLOBE	Vaxart Announces $10.0 Million Registered Direct Offering..
2024/1/16	23:22	GLOBE	Vaxart, Inc. Announces Management Change
2024/1/16	23:19	EDGAR2	Form 8-K - Current report
2023/12/21	22:00	GLOBE	Vaxart Announces Last Subject Dosed in Phase 1 Trial of Its..
2023/11/03	05:16	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/03	05:11	EDGAR2	Form 8-K - Current report
2023/11/03	05:01	GLOBE	Vaxart Provides Business Update and Reports Third Quarter..
2023/11/02	21:00	GLOBE	Vaxart Doses First Subject in Phase 1 Trial of Its Norovirus..
2023/10/26	21:00	GLOBE	Vaxart to Host Third Quarter 2023 Business Update and..
2023/10/24	06:09	EDGAR2	Form 8-K/A - Current report: [Amend]
2023/10/24	06:01	EDGAR2	Form 8-K - Current report
2023/10/11	21:00	GLOBE	Vaxart to Present at World Vaccine Congress Europe 2023 on..
2023/9/21	21:00	GLOBE	Vaxart to Participate in Fireside Chat at 2023 Cantor Global..